J Bluestone
Overview
Explore the profile of J Bluestone including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
455
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shoda L, Kreuwel H, Gadkar K, Zheng Y, Whiting C, Atkinson M, et al.
Clin Exp Immunol
. 2010 May;
161(2):250-67.
PMID: 20491795
Type 1 diabetes is an autoimmune disease whose clinical onset signifies a lifelong requirement for insulin therapy and increased risk of medical complications. To increase the efficiency and confidence with...
2.
Diamond B, Bluestone J, Wofsy D
Arthritis Rheum
. 2001 Aug;
44(8):1730-5.
PMID: 11508422
The development of effective, new, biologically based therapies for RA has created real excitement and justifiable optimism in recent years among rheumatologists and among patients with rheumatic diseases. Recent advances...
3.
Reardon C, Blachowicz L, White T, Cabana V, Wang Y, LUKENS J, et al.
Arterioscler Thromb Vasc Biol
. 2001 Jun;
21(6):1011-6.
PMID: 11397712
To determine whether T cells and B cells influence lipid metabolism and atherosclerosis, we crossed apolipoprotein E-deficient (apoE degrees ) mice with recombination activating gene 2-deficient (RAG2 degrees ) mice....
4.
Role of STAT6 signaling in the induction and long-term maintenance of tolerance mediated by CTLA4-Ig
Zhou P, Szot G, Guo Z, Kim O, He G, Wang J, et al.
Transplant Proc
. 2001 Mar;
33(1-2):214-6.
PMID: 11266784
No abstract available.
5.
Alegre M, Fallarino F, Zhou P, Frauwirth K, Thistlethwaite J, Newell K, et al.
Transplant Proc
. 2001 Mar;
33(1-2):209-11.
PMID: 11266782
No abstract available.
6.
Punch J, Lin J, Bluestone J, Bromberg J
Transplantation
. 1999 Mar;
67(5):741-8.
PMID: 10096532
Background: Antigen specific allograft tolerance is induced in mice by anti-CD2 plus anti-CD3epsilon monoclonal antibody (mAb) treatment. Because anti-CD2 mAb inhibits several aspects of anti-CD3epsilon driven T cell activation, we...
7.
Cantrell D, Bluestone J, Vivier E, Tybulewicz V
Res Immunol
. 1999 Jan;
149(9):866-7.
PMID: 9923642
No abstract available.
8.
Yang Y, Zou J, Mu J, Wijesuriya R, Ono S, Walunas T, et al.
Cancer Res
. 1997 Oct;
57(18):4036-41.
PMID: 9307290
Cytotoxic T lymphocyte-associated molecule-4 (CTLA-4), a second counterreceptor for the B7 family of costimulatory molecules, functions as a negative regulator of T-cell activation. Here, we investigated whether the blockade of...
9.
Perkins D, Wang Z, Donovan C, He H, Mark D, Guan G, et al.
J Immunol
. 1996 Jun;
156(11):4154-9.
PMID: 8666782
T cell activation requires at least two distinct signals, including signaling via the Ag-specific TCR and a costimulatory pathway. The best characterized costimulatory pathway involves the CD28 molecule, which is...
10.
Sydora B, Mixter P, Houlden B, HERSHBERG R, Levy R, Comay M, et al.
Cell Immunol
. 1993 Dec;
152(2):305-22.
PMID: 8258140
The phenotype, T-cell antigen receptor (TCR) usage and specificity of intestinal intraepithelial lymphocytes (IEL), and hybridomas derived from IEL have been examined. In young conventionally reared mice, approximately 50% of...